(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
Cancer.gov
UpToDate
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
Patient Power